Enveric Biosciences (ENVB) EBIT Margin (QoQ) (2015 - 2020)
Enveric Biosciences (ENVB) EBIT Margin (QoQ) (2015 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Enveric Biosciences | 5.66 Mn | -2.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 352.00 |
| Jun 30, 2020 | -58.00 |
| Mar 31, 2020 | -3,125.00 |
| Dec 31, 2019 | 3,965.00 |
| Sep 30, 2019 | -370.00 |
| Jun 30, 2019 | -125.00 |
| Mar 31, 2019 | 9,288.00 |
| Dec 31, 2018 | -16,271.00 |
| Sep 30, 2018 | 6,743.00 |
| Jun 30, 2018 | 261.00 |
| Mar 31, 2018 | 1,569.00 |
| Dec 31, 2017 | 344.00 |
| Sep 30, 2017 | -289.00 |
| Jun 30, 2017 | -2,349.00 |
| Mar 31, 2017 | 1,241.00 |
| Dec 31, 2016 | -468.00 |
| Sep 30, 2016 | 117.00 |
| Jun 30, 2016 | -1.00 |
| Mar 31, 2016 | 889.00 |
| Dec 31, 2015 | -1,581.00 |